< Back to latest news & events

Knowledge Hub

UPC – Preparatory Committee Proposes Court Fees

May 2015

Over 2 years after the Agreement on the Unitary Patent Court was signed, the Preparatory Committee has published proposed Court fees and launched a public consultation on the fee structure for the Court.

The consultation document comprises of two options revising the Rules of Procedure, including a table of fees, a scale of ceilings for recoverable costs and an Explanatory Note.

The Committee have said that “The fee structure for the Unified Patent Court will comprise fixed fees and, for certain actions, an additional value based fee. The fee levels proposed are the lowest that will enable eventual sustainability of the Court”. Two alternatives have been set out.

Given that the Unitary Patent and UPC have been championed by the European Parliament to “cut costs for small firms and tailored the regime to their needs…” it may be surprising that both the proposed alternatives include a minimum fixed fee of €11, 000 to bring an infringement action before the UPC. Furthermore, for claims with a value greater than €500,000, a value-based fee will also be payable (increasing with value of the action). Counter claims for revocation have the same fixed fee, and revocations, higher still at €20,000. Ceiling levels for recoverable costs are also proposed, starting at €50,000 for a €250, 000 action.

There are options for seeking reductions; in one alterative, reimbursements may be available if the action is settled or withdrawn and in the other alternative, SMEs, micro entities and the like, may apply for an exemption (this will only apply to the value based fees).

More welcome news will be the proposal that an opt-out fee, to remove a European patent from the jurisdiction of the UPC, should be set at €80, and this will be applicable to each patent, and not each designation. Comments (electronically to the secretariat@unified-patent-court.org before midnight on the 31 July) are welcomed on any aspect of the proposal and will be considered by the Preparatory Committee and its appropriate Working Groups prior to publication of an agreed fee structure.

Latest updates

A New Era for AI Patents in the UK: Supreme Court Aligns with the EPO

The UK Supreme Court has handed down its long-awaited judgment in Emotional Perception AI Limited (EPAI) vs Comptroller General of Patents, a decision which serves to significantly change the way …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details